Dr. Landau - ASH 2008 - Sequential Administration of Bortezomib, Liposomal Doxorubicin and Dexamethasone (BDD) Followed by Thalidomide and Dexamethasone (TD) Results in Rapid Control of Untreated High-Risk Multiple Myeloma (MM) and Improves Depth of Response
Heather Landau, MD Memorial Sloan-Kettering Cancer Center New York, New York U.S.A.
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.